These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35530654)

  • 1. Impact of Hippocampal Avoidance - Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients.
    Maragkoudakis E; Kouloulias V; Grenzelia M; Kougioumtzopoulou A; Zygogianni A; Ramfidis V; Charpidou A
    Cancer Diagn Progn; 2022; 2(3):279-284. PubMed ID: 35530654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.
    Qu XM; Mishra MV; Bauman GS; Slotman B; Mehta M; Gondi V; Louie AV
    Radiother Oncol; 2017 Mar; 122(3):411-415. PubMed ID: 28109544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance and safety of hippocampal avoidance prophylactic cranial irradiation in the multicenter randomized phase III trial (NCT01780675).
    Candiff O; Belderbos J; Wolf AL; Damen E; van Haaren P; Crijns W; Hol S; Paelinck L; van Kesteren Z; Jaspers J; de Kerf G; van Elmpt W; Ubbels F; Schagen S; de Ruysscher D; de Ruiter M
    J Natl Cancer Cent; 2023 Jun; 3(2):135-140. PubMed ID: 39035727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
    Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
    J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
    Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
    Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
    Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z
    Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of relapse following hippocampal avoidance prophylactic cranial irradiation for small cell lung carcinoma.
    Cook TA; Hoffmann MR; Ross AJ; Turnbull KJ; Westhuyzen J; Aherne NJ
    Rep Pract Oncol Radiother; 2021; 26(6):968-975. PubMed ID: 34992870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic cranial irradiation (PCI), hippocampal avoidance (HA) whole brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) in small cell lung cancer (SCLC): Where do we stand?
    Crockett C; Belderbos J; Levy A; McDonald F; Le Péchoux C; Faivre-Finn C
    Lung Cancer; 2021 Dec; 162():96-105. PubMed ID: 34768007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small cell lung cancer reduces hippocampal atrophy compared to conventional PCI.
    de Ruiter MB; Groot PFC; Deprez S; Pullens P; Sunaert S; de Ruysscher D; Schagen SB; Belderbos J
    Neuro Oncol; 2023 Jan; 25(1):167-176. PubMed ID: 35640975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis.
    Mayinger M; Kraft J; Lohaus N; Weller M; Schanne D; Heitmann J; Willmann J; Wilke L; Krayenbuehl J; Tanadini-Lang S; Guckenberger M; Andratschke N
    Eur J Cancer; 2020 Jan; 124():194-203. PubMed ID: 31812935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review.
    Zeng H; Hendriks LEL; van Geffen WH; Witlox WJA; Eekers DBP; De Ruysscher DKM
    Cancer Treat Rev; 2020 Aug; 88():102025. PubMed ID: 32512415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perihippocampal Meningeal Carcinomatosis Following Hippocampal Avoidance Prophylactic Cranial Irradiation in Small Cell Lung Cancer: A Case Report.
    Fujiwara M; Tada H
    Cureus; 2023 Oct; 15(10):e46499. PubMed ID: 37927701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal avoidance in prophylactic cranial irradiation for small cell lung cancer: benefits and pitfalls.
    Abraham AG; Roa W
    J Thorac Dis; 2021 May; 13(5):3235-3245. PubMed ID: 34164216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis.
    Yin X; Yan D; Qiu M; Huang L; Yan SX
    BMC Cancer; 2019 Jan; 19(1):95. PubMed ID: 30665432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12).
    Vees H; Caparrotti F; Eboulet EI; Xyrafas A; Fuhrer A; Meier U; Mark M; Elicin O; Aebersold DM; Zwahlen DR; Finazzi T; Allal AS; Putora PM; Martucci F; Rudolf CB; Ribi K;
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):279-287. PubMed ID: 32142869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.
    Nawrocki S; Sugajska A
    BMC Cancer; 2020 Mar; 20(1):231. PubMed ID: 32188425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
    Belderbos JSA; De Ruysscher DKM; De Jaeger K; Koppe F; Lambrecht MLF; Lievens YN; Dieleman EMT; Jaspers JPM; Van Meerbeeck JP; Ubbels F; Kwint MH; Kuenen MA; Deprez S; De Ruiter MB; Boogerd W; Sikorska K; Van Tinteren H; Schagen SB
    J Thorac Oncol; 2021 May; 16(5):840-849. PubMed ID: 33545387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Prophylactic Cranial Irradiation Versus MRI Surveillance for Extensive-Stage Small Cell Lung Cancer.
    Kim H; Keller A; Beriwal S; Smith KJ; Vargo JA
    Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):1186-1194. PubMed ID: 33984410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675).
    Albers EAC; Zeng H; De Ruysscher DKM; Kuenen MA; Kessels R; Hendriks LEL; Belderbos JSA; Schagen SB
    JTO Clin Res Rep; 2023 May; 4(5):100506. PubMed ID: 37284297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
    Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.